Immune
Defiency
Syndrome
(AIDS)
Daerah
(KPAD)
Dalam
34
16. Tuberculosis Coalition for Technical Assistance. Tuberculosis Coalition for Technical
Assistance, International Standards for Tuberculosis Care (ISTC). 2006. The Hague.
17. Anonym. Referat HIV/AIDS. Dapat diunduh pada:
http://www.qitepscience.org/resources/artikel/REFERATHIVAIDS.pdf. [diakses pada
tanggal 9 April 2016].
18. Anonym. Informasi Dasar HIV/AIDS. 2011. Dapat diunduh pada:
http://aidsina.org/modules.php?name=FAQ&myfaq=yes&id_cat=1&categories=HIVAIDS. [diakses pada tanggal 9 April 2016].
19. Tuberculosis Coalition for Technical Assistance. Tuberculosis Coalition for Technical
Assistance, International Standards for Tuberculosis Care (ISTC) Edisi Kedua. 2009.
The Hague.
20. Departemen Kesehatan RI. 2009. Modul kolaborasi Tb-HIV. Jakarta: Direktorat
Jendral Pengendalian Penyakit dan Penyehatan Lingkungan Depkes RI.
21. World Health Organization. 2004. Tb-HIV a clinical manual Edisi kedua. Geneva:
WHO.
22. Departemen Kesehatan RI. 2009. Pedoman Nasional Terapi Antiretroviral Edisi
Kedua. Jakarta: Direktorat Jendral Pengendalian Penyakit dan Penyehatan
Lingkungan Depkes RI.
23. Handayani, S. 2002. Respon Imunitas Seluler Pada Infeksi Tuberkulosis Paru.
Jakarta: Cermin Dunia Kedokteran. 2002; 137:34-37.
24. Departemen Kesehatan RI. 2007. Kebijakan Nasional Kolaborasi Tb/HIV. Jakarta:
Depkes RI.
25. World Health Organization. 2006. Tuberculosis infection control in the era of
expanding HIV care and treatment. Geneva: WHO.
26. Kelompok Kerja Tb-HIV Tingkat Pusat. 2003. Prosedur Tetap Pencegahan dan
Pengobatan Tuberkulosis pada Orang dengan HIV/AIDS. Jakarta: Depkes RI.
27. Departemen Kesehatan RI. 2007. Pedoman Nasional Penanggulangan Tuberkulosis
Edisi kedua. Jakarta: Depkes RI.
28. Burman Wj, Jones BE. 2001. Treatment of HIV-related Tuberculosis in the Era of
Effective Antiretroviral Theraphy. Am J Respir Crit Care Med. 2001; 164:7-12.
29. Departemen Kesehatan RI. 2009. Pedoman Nasional Terapi Antiretroviral. Jakarta:
Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan Depkes RI.
30. World Health Organization. 2006. Improving the Diagnosis and Treatment of Smearnegative Pulmonary and Extrapulmonary Tuberculosis among Adults and
Adolescents. Geneva: WHO.
31. World Health Organization. 2010. Antiretroviral Theraphy for HIV Infection in Adults
and Adolescents Recommendations for a Public Health Approach. Geneva: WHO.
35
32. Piscitelli SC, Gallicano ED. 2001. Interactions among Drugs for HIV and
Opportunistic Infections. N Eng J Med 2001; 344 (13): 984-996.
33. National Center for HIV/AIDS, Viral Hepatitis, STD, and Tb Prevention Division of
Tuberculosis Elimination. 2007. Managing Drug Interactions in the Treatment of
HIV-realted Tuberculosis. Atlanta: CDC.
34. Carr A, Cooper DA. 2000. Adverser Effects of Antiretroviral Theraphy. Lancet 2000;
356: 1423-30.
35. Montessori V, Press N, Harris M, Akagi L, Montaner JS. 2004. Adverse Effects of
Antiretroviral Theraphy for HIV Infection. CMAJ 2004; 170 (2): 229-38.
36. World Health Organization. 2007. Prioritizing Second-line Antiretroviral Drugs for
Adults and Adolescents: Public Health Approach. Geneva: WHO.
37. Clavel F and Hance AJ. 2004. Medical Progress HIV Drug Resistance. N Engl J Med
2004; 350:1023-35.
38. Feirer J. 2006. MDR-TB and HIV : The Perfect Storm? Editorial. Am J Trop Med
Hyg 2006; 75(6):1025-1026.
39. Anonym. 2010. Laju HIV/AIDS Indonesia Tercepat di Asia. Dapat diunduh pada:
http://www.aidsindonesia.or.id/lajuhivaids-indonesia-tercepat-di-asia.html.
pada tanggal 9 April 2016].
[diakses